LTM Secures $100 Mn Multi-Year Deal with European MedTech

Under the agreement, LTM will develop and maintain the MedTech company’s core hearing instrument brands as well as its private label products.

LTM, a global business creativity partner, has announced a strategic seven-year agreement valued at $100 million with a European medical technology company specializing in innovative hearing solutions. The deal covers product development, support, and regulatory guidance across the client’s flagship offerings.

Under the agreement, LTM will develop and maintain the MedTech company’s core hearing instrument brands as well as its private label products. The scope includes wearable devices, the professional fitting application used by hearing care providers to configure hearing aids, and the consumer-facing mobile app for device control.

To deliver on this partnership, LTM will deploy its iNXT platform, a cross-industry digital transformation and innovation tool that supports the convergence of physical and digital product ecosystems. The platform is expected to streamline development processes, enhance product functionality, and ensure compliance with complex MedTech regulatory standards.

In addition to technological support, LTM will lead regulatory and compliance navigation for the MedTech partner, ensuring adherence to evolving European medical device standards. The collaboration positions LTM to extend its expertise in digital product innovation and enterprise-level MedTech solutions.

Stay tuned for more such updates on Digital Health News